196 related articles for article (PubMed ID: 35834513)
1. The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis.
Chewcharat A; Chewcharat P; Liu W; Cellini J; Phipps EA; Melendez Young JA; Nigwekar SU
PLoS One; 2022; 17(7):e0271307. PubMed ID: 35834513
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis.
Lynch KE; Feldman HI; Berlin JA; Flory J; Rowan CG; Brunelli SM
Am J Kidney Dis; 2008 Nov; 52(5):962-71. PubMed ID: 18706751
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial.
Ibarra-Sifuentes HR; Del Cueto-Aguilera Á; Gallegos-Arguijo DA; Castillo-Torres SA; Vera-Pineda R; Martínez-Granados RJ; Atilano-Díaz A; Cuellar-Monterrubio JE; Pezina-Cantú CO; Martínez-Guevara EJ; Ortiz-Treviño JF; Delgado-García GR; Martínez-Jiménez JG; Cruz-Valdez J; Sánchez-Martínez C
Ther Apher Dial; 2017 Oct; 21(5):459-464. PubMed ID: 28805348
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the relationship between serum carnitine levels and intradialytic complications in children with kidney failure.
Bazargani B; Mojtahedi SY; Fahimi D; Askarian F; Moghtaderi M; Abbasi A; Samimi M; Bakhtiari Koohsorkhi M
Pediatr Nephrol; 2022 Sep; 37(9):2179-2183. PubMed ID: 35118545
[TBL] [Abstract][Full Text] [Related]
6. Carnitine supplements for people with chronic kidney disease requiring dialysis.
Nishioka N; Luo Y; Taniguchi T; Ohnishi T; Kimachi M; Ng RC; Watanabe N
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013601. PubMed ID: 36472884
[TBL] [Abstract][Full Text] [Related]
7. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
Schreiber BD
Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
[TBL] [Abstract][Full Text] [Related]
8. Magnesium for skeletal muscle cramps.
Garrison SR; Korownyk CS; Kolber MR; Allan GM; Musini VM; Sekhon RK; Dugré N
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD009402. PubMed ID: 32956536
[TBL] [Abstract][Full Text] [Related]
9. Significance of Levocarnitine Treatment in Dialysis Patients.
Takashima H; Maruyama T; Abe M
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917145
[TBL] [Abstract][Full Text] [Related]
10. Results of a single blind, randomized, placebo-controlled clinical trial to study the effect of intravenous L-carnitine supplementation on health-related quality of life in Indian patients on maintenance hemodialysis.
Rathod R; Baig MS; Khandelwal PN; Kulkarni SG; Gade PR; Siddiqui S
Indian J Med Sci; 2006 Apr; 60(4):143-53. PubMed ID: 16679630
[TBL] [Abstract][Full Text] [Related]
11. Low dialysate sodium levels for chronic haemodialysis.
Dunlop JL; Vandal AC; Marshall MR
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
[TBL] [Abstract][Full Text] [Related]
12. Magnesium for skeletal muscle cramps.
Garrison SR; Allan GM; Sekhon RK; Musini VM; Khan KM
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009402. PubMed ID: 22972143
[TBL] [Abstract][Full Text] [Related]
13. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lowering the Dialysate Temperature in Chronic Hemodialysis: A Systematic Review and Meta-Analysis.
Mustafa RA; Bdair F; Akl EA; Garg AX; Thiessen-Philbrook H; Salameh H; Kisra S; Nesrallah G; Al-Jaishi A; Patel P; Patel P; Mustafa AA; Schünemann HJ
Clin J Am Soc Nephrol; 2016 Mar; 11(3):442-57. PubMed ID: 26712807
[TBL] [Abstract][Full Text] [Related]
15. Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis.
Zhu Y; Xue C; Ou J; Xie Z; Deng J
Int Urol Nephrol; 2021 Oct; 53(10):2149-2158. PubMed ID: 33713287
[TBL] [Abstract][Full Text] [Related]
16. L-carnitine in dialysis patients.
Ahmad S
Semin Dial; 2001; 14(3):209-17. PubMed ID: 11422928
[TBL] [Abstract][Full Text] [Related]
17. Levocarnitine and dialysis: a review.
Schreiber B
Nutr Clin Pract; 2005 Apr; 20(2):218-43. PubMed ID: 16207659
[TBL] [Abstract][Full Text] [Related]
18. Carnitine and hemodialysis.
Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
[TBL] [Abstract][Full Text] [Related]
19. Effects of L-carnitine supplementation on the quality of life in diabetic patients with muscle cramps.
Imbe A; Tanimoto K; Inaba Y; Sakai S; Shishikura K; Imbe H; Tanimoto Y; Terasaki J; Imagawa A; Hanafusa T
Endocr J; 2018 May; 65(5):521-526. PubMed ID: 29515058
[TBL] [Abstract][Full Text] [Related]
20. Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients.
Higuchi T
Contrib Nephrol; 2018; 196():96-100. PubMed ID: 30041211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
